DBS Group Holdings Ltd
DBSDF News Today: Stay Updated with the Latest DBS Group Holdings Ltd News in Real Time
Find DBSDF news now at Meyka AI. Stay informed with the latest DBS Group Holdings Ltd stocks updates, including price news, market analysis, and expert insights.
Stock Market Today: Nasdaq Futures Rise 0.6% as S&P 500 Gains 0.4%
Global investors started the trading session on a positive note as U.S. futures moved higher, signaling renewed optimism across financial markets. Nasdaq futures climbed 0.6 percent, while the S&P 500 futures added 0.4 percent, reflecting stronger sentiment driven by technology stocks, improving economic expectations, and continued interest in AI stocks. Market analysts highlighted that easing…
April 06: Stephen Miller’s Immigration Drive Puts Labor, CPI at Risk
Stephen Miller immigration agenda could tighten U.S. labor, lift food inflation, and sway CPI and Fed bets, posing near-term risks for S&P 500 investors.
KMD.AX down 54.84% to A$0.07 on ASX, market closed: short-term outlook
KMD.AX stock fell 54.84% to A$0.07 on ASX, market closed. Meyka AI analysis, grade and forecast included
April 6: Cuba Prisoner Release Signals US Tensions, Oil Supply Risk
Cuba prisoner release under US pressure signals policy shifts and Caribbean oil supply risk. What this means for Canadian fuel prices, shipping costs, and energy exposure.
ANGGF (Angang Steel, PNK) $0.26 in market hours 06 Apr 2026: analyst targets
ANGGF stock update: Angang Steel at $0.26 in market hours on 06 Apr 2026 with Meyka AI forecast and analyst context
Bitcoin USD Holds $69,500 as April CPI Data Shapes Next Move
Bitcoin USD trades at $69,507 with 3.9% gains. Technical analysis shows RSI at 41.28 and strong ADX trend. April 10 CPI data critical for direction.
005930.KS Stock Today: April 6 — Target Hiked as Profit Seen >KRW300T
Samsung Electronics price target lifted to KRW 330,000 as 2026 operating profit is forecast above KRW 300 trillion. What this means for HK investors amid DRAM price surge and HBM4 mass production.
Neurocrine Biosciences Close to $2.5B Acquisition of Soleno Therapeutics
We’re seeing a major move in biotech today. Neurocrine Biosciences is close to completing a deal to acquire Soleno Therapeutics in a transaction worth more than $2.5 billion, potentially rising to about $2.9 billion in cash. This deal is one of the most notable biotech acquisitions so far in 2026, and it aligns with Neurocrine’s growth strategy…
April 6: Mozzi’s ‘Demands’ Signal Reputation Risk for Banda, US Move
Edoardo Mapelli Mozzi demands and a possible Princess Beatrice US move raise governance and reputation risks for Banda’s property business. We assess implications for UK investors, fundraising, lender